In the present study, the physico-metabolic parameters measured were: serum insulin, serum lipid profile, serum biomarker enzymes and anti-oxidant enzymes, total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol, VLDL cholesterol, total proteins, alanine transaminase (ALT), aspartate transaminase (AST), creatinine, insulin assay (RIA), for in vivo anti-oxidant activity of MECC was measured in liver tissue homogenate (LTH) by malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD) enzymes and histopathological examination of pancreas were also observed. Previously, the methonolic extract of Cressa cretica Linn. effect on alloxan induced hyperglycemic Wistar rats was proved by taking the parameters like body weight, blood glucose, glycogen content in liver and muscle. Oral administration of MECC (200 mg/kg, 400 mg/kg) for 28 days exhibited a significant reduction in blood glucose, serum ALT, AST, CR, lipid profile and hepatic MDA levels. The improvement of hepatic enzymes such as GSH, serum TP, HDL, insulin levels were also observed. The results of this work also suggest that MECC may possess anti-hyperglycemic and anti-oxidant property.
Introduction
Chronic metabolic disorder named Diabetes mellitus II is characterized by high blood glucose levels due to absolute deficiency of circulating insulin levels (Venkatesh et al., 2003) . This disease affects more than 15 million people showing complications that include hypertension, atherosclerosis and microcirculatory disorders (Vivek et al., 2010) . Cressa cretica Linn. (Convolvulaceae), used in diabetes and many other diseases (Vaidyaratnam, 1997) . Presently, the effect of Cressa cretica Linn. methanolic extract on alloxan induced hyperglycemic Wistar rats was undertaken.
Materials and methods
Cressa cretica Linn. plant extract was prepared and suspended in 1% Tween-80 and used as oral administrant.
Experimental animals
Healthy male Wistar rats weighing between 150 and 200 g, were procured and experiments were designed in the following manner. The rats were divided into six groups consisting of six rats each.
Group I: Euglycemic or normal animals (normal saline 5 ml/kg, once daily) 
Results and discussion
Preliminary phytochemical analysis of MECC showed the presence of flavonoids and terpenoids. The acute toxicity study in rats produced no death or signs of toxicity even at high dose (5 g/kg) of the extract. In anti-diabetic study, the effect of various treatments on serum lipid profile, serum biomarker enzymes, serum insulin, anti-oxidant enzymes in LTH, MDA were studied and showed graphically (Figs. 1-4) (Grover et al., 2002) . Pancreas of normal control and various treated diabetic rats were kept in 40% formalin later submitted to Jeevan Regional Diagnostics, Belgaum, Karnataka for histopathological studies. The specimens were processed by standard procedure and embedded in paraffin wax. The blocks were sectioned from the ventricular portion and 5 thick sections were stained according to the haematoxylin and eosin (H&E) method given by Smith and Burton. The sections were examined by light microscopy and micrographs were shown (Fig. 5) .
Conclusion
The results obtained from the present study demonstrated that the orally administered high dose (400 mg/kg) of MECC significantly decreases the elevate blood sugar level, serum lipid profile, serum biomarker enzymes and significantly increased insulin, glycogen content in liver and muscle, possesses anti-oxidant property by virtue of its normalizing the impaired oxidative stress defence mechanism in the hyperglycemic rats.
Cressa cretica Linn. has been already proved to have anti-inflammatory and anti-fungal activity by virtue of its anti-oxidant constituents. So, this present study on antihyperglycemic activity also proved due to these active principles. Cressa cretica Linn. offers significant hypoglycemic agent in terms of preservation of endogenous anti-oxidants, scavenging of superoxide and hydroxyl radicals and inhibition of lipid per oxidation.
